BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11503322)

  • 1. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Swaak AJ; Theunissen DJ
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1476-7; author reply 1477-8. PubMed ID: 11503322
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Houben JJ; Liem B
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2338. PubMed ID: 10589225
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of nimesulide, meloxicam and rofecoxib as alternative analgesics.
    Karakaya G; Kalyoncu AF
    Allergol Immunopathol (Madr); 2000; 28(6):319-21. PubMed ID: 11269899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific cyclo-oxygenase inhibitors. 2. Gastric toxicity?].
    Blondon H
    Presse Med; 2000 Mar; 29(9):482-3. PubMed ID: 10745938
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclooxygenase inhibition: between the devil and the deep blue sea.
    Hawkey CJ
    Gut; 2002 May; 50 Suppl 3(Suppl 3):III25-30. PubMed ID: 11953329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib- and rofecoxib-induced delirium.
    Macknight C; Rojas-Fernandez CH
    J Neuropsychiatry Clin Neurosci; 2001; 13(2):305-6. PubMed ID: 11449042
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular events and COX-2 inhibitors.
    Fleming M
    JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
    [No Abstract]   [Full Text] [Related]  

  • 9. A side effect of COX-2 inhibitors.
    Harv Health Lett; 2003 Apr; 28(6):7. PubMed ID: 12777233
    [No Abstract]   [Full Text] [Related]  

  • 10. Celecoxib and rofecoxib.
    Brinker AD; Bonnel RA; Feight AG; Nourjah P
    J Am Dent Assoc; 2001 Nov; 132(11):1502, 1504. PubMed ID: 11806062
    [No Abstract]   [Full Text] [Related]  

  • 11. Concerns about COX-2 painkillers. They're easier on the stomach, potentially harder on your heart.
    Heart Advis; 2002 Jan; 5(1):2. PubMed ID: 16145759
    [No Abstract]   [Full Text] [Related]  

  • 12. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Lems WF; van de Laar MA; Bijlsma JW
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1044-7. PubMed ID: 11414163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arthritis. Should you be taking a COX-2 inhibitor?
    Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D; Hughes K; Harris S; Shakir SA
    Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are rofecoxib and celecoxib safer NSAIDS?
    Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure control and rates of edema following the administration of the cyclooxygenase-2 specific inhibitors celecoxib versus rofecoxib in patients with systemic hypertension and osteoarthritis.
    Weaver A; Alderman M; Sperling R
    Am J Cardiol; 2003 May; 91(10):1291-2. PubMed ID: 12745131
    [No Abstract]   [Full Text] [Related]  

  • 17. Celecoxib, rofecoxib, and acute temporary visual impairment.
    Coulter DM; Clark DW; Savage RL
    BMJ; 2003 Nov; 327(7425):1214-5. PubMed ID: 14630760
    [No Abstract]   [Full Text] [Related]  

  • 18. Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database.
    Lugardon S; Lapeyre-Mestre M; Montastruc JL
    Eur J Clin Pharmacol; 2004 Nov; 60(9):673-7. PubMed ID: 15517227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summaries for patients. Cyclooxygenase-2 inhibitors and heart attacks: varying effects?
    Ann Intern Med; 2005 Feb; 142(3):I21. PubMed ID: 15684199
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclooxygenase (COX-2) selective inhibitors. Any better than NSAIDs?
    Nguyen A; Chaiton A
    Can Fam Physician; 2001 Jul; 47():1398-400. PubMed ID: 11494927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.